The recent rulings and cases highlight the complexities surrounding imminent patent infringement in the pharmaceutical industry. Pharmaceutical patent disputes are subject to certain specialized procedures under the HatchWaxman Act and the.Patent litigation is the process through which one party sues another for making allegedly unlawful claims upon their patented invention. 2023 IP Outlook: Patent Decisions Affecting Pharma and Biotech Companies shares what businesses should look out for in 2023. This article explains how patents function in the pharmaceutical industry. Patent infringement in the pharmaceutical industry can be a complex and challenging issue to navigate. Prior to this ruling, companies suing for patent infringement often sued in the Federal Eastern District of Texas. The date shown in the middle column above indicates when each form was last revised. Her experience includes representing a multinational cybersecurity and anti-virus provider in a cybersecurity patent infringement matter. Watch for the Supreme Court's ruling and its potential effects on patent litigation in the year to come.